Luna Innovations Appoints Kevin Ilcisin As Its New President And CEO, Effective August 1, 2024

7/23/24 5:38:41 PM ET

Biotechnology: Commercial Physical & Biological Resarch

Health Care

Get the next $LUNA alert in real time by email

The company also announced the retirement of Richard Roedel from the Board of Directors after nearly 20 years of service, and the closing of a $15 million junior secured term loan facility.

Ilcisin succeeds Richard Roedel, who informed the Board on July 12, 2024, that, after nearly 20 years of dedicated service to the Company, he was stepping down as Interim President and Interim Executive Chairman of the Company due to health reasons, effective immediately.

On July 16, 2024, Warren B. (Barry) Phelps, III was appointed Chair of the Board of Directors.

Get the next $LUNA alert in real time by email

Chat with this insight

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$LUNA

Date	Price Target	Rating	Analyst
7/28/2023	$12.50	Buy	Stifel
5/22/2023	$10.00	Buy	Needham
3/15/2023	$8.00	Outperform → Market Perform	Northland Capital
5/23/2022	$8.00	Market Perform → Outperform	Northland Capital

More analyst ratings

$LUNA
Financials

Live finance-specific insights

Luna Innovations to Delay Release of Fourth Quarter and Full Year 2023 Financial Results
Luna Innovations Incorporated (NASDAQ:LUNA) (the "Company"), a global leader in advanced fiber optic-based technology, today announced it will delay the release of its fourth quarter and fiscal year 2023 financial results and the subsequent conference call. A Special Committee of the Company's Board of Directors is conducting an independent review, with the assistance of external legal and financial advisors, of certain transactions for which revenue was recognized in the second and third quarters of 2023 that did not qualify for revenue recognition under U.S. generally accepted accounting principles. The Special Committee is examining the circumstances surrounding these issues and is eva
3/12/24 4:20:00 PM ET
$LUNA
Biotechnology: Commercial Physical & Biological Resarch
Health Care
Luna Announces $50 Million Strategic Investment from White Hat Capital Partners
Investment Proceeds Used to Fund Silixa Acquisition and Enhance Luna's Financial Flexibility to Pursue Strategic Growth Initiatives Luna Innovations Incorporated (NASDAQ:LUNA), a global leader in advanced fiber optic-based technology, today announced a $50 million investment by White Hat Capital Partners ("White Hat"), an investment firm focused on sustainable value creation in technology companies serving mission-critical applications. Proceeds from this strategic investment were partially used to fund the acquisition of Silixa, also announced today, and related transaction costs in the aggregate amount of approximately $25 million. Remaining proceeds were used to repay the Company's o
12/21/23 9:34:00 AM ET
$LUNA
Biotechnology: Commercial Physical & Biological Resarch
Health Care
Luna Acquires Silixa
Strengthens Portfolio of Distributed Fiber Optic Sensing Solutions Adds Significant New Growth Markets and Applications and Further Expands Global Footprint Conference Call Scheduled for Today, December 21st, at 11:00 AM ET Luna Innovations Incorporated (NASDAQ:LUNA), a global leader in advanced fiber optic-based technology, today announced the strategic acquisition of Silixa, a UK-based leader in distributed fiber optic sensing solutions. The acquisition further propels Luna's position in the fiber optic sensing market, adding capabilities in distributed acoustic sensing (DAS), distributed temperature sensing (DTS) and distributed strain sensing (DSS) that offer enhanced performance
12/21/23 9:32:00 AM ET
$LUNA
Biotechnology: Commercial Physical & Biological Resarch
Health Care

Luna Innovations Announces CFO Transition: Names William Phelan as Chief Financial Officer and Chief Accounting Officer
Luna Innovations Incorporated (NASDAQ:LUNA), a global leader in advanced fiber optic-based technology, today announced the appointment of William L. Phelan as its new Chief Financial Officer and Chief Accounting Officer, effective immediately. Mr. Phelan succeeds John Roiko, who joined Luna out of retirement in May 2024 and played a key role in establishing a resilient foundation for Luna's future growth. Following the appointment of Mr. Phelan, Mr. Roiko will shift to a consulting role to support the ongoing restatement process. "We are delighted to welcome Bill to the Luna leadership team," said Kevin Ilcisin, President and CEO of Luna. "Bill's highly relevant experience will be instrume
10/16/24 4:30:00 PM ET
$LUNA
Biotechnology: Commercial Physical & Biological Resarch
Health Care
Luna Announces Appointment of Kevin Ilcisin as CEO, Retirement of Richard Roedel and $15 Million Credit Facility from White Hat Capital Partners
Luna Innovations Incorporated (NASDAQ:LUNA) (the "Company"), a global leader in advanced fiber optic-based technology, today announced the appointment of Kevin Ilcisin as its new President and Chief Executive Officer, the retirement of Richard Roedel from the Board of Directors (the "Board") after nearly 20 years of service, and the closing of a $15 million junior secured term loan facility (the "Loan Facility"). New President and CEO: Effective August 1, 2024, Mr. Ilcisin will assume his new role as the President, CEO and member of the Board of the Company. Mr. Ilcisin has been a strategic advisor to the Company since April 2024, bringing a wealth of experience, industry knowledge and
7/23/24 5:36:00 PM ET
$LUNA
Biotechnology: Commercial Physical & Biological Resarch
Health Care
Luna Innovations Incorporated investors: Please contact the Portnoy Law Firm to recover your losses; May 31, 2024 deadline
Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, May 28, 2024 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Luna Innovations Incorporated (NASDAQ:LUNA) investors that a lawsuit was filed on behalf of investors that purchased Luna securities between May 16, 2022 and April 19, 2024 inclusive (the "Class Period"). Investors are encouraged to contact attorney Lesley F. Portnoy, by phone 310-692-8883 or email: [email protected], to discuss their legal rights, or click here to join the case via www.portnoylaw.com. The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors' options for pursuing claims to
5/28/24 6:25:35 PM ET
$LUNA
Biotechnology: Commercial Physical & Biological Resarch
Health Care

$LUNA
Press Releases

Fastest customizable press release news feed in the world

Luna Innovations Receives Additional Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q
Luna Innovations Incorporated (NASDAQ:LUNA) (the "Company"), a global leader in advanced fiber optic-based technology, today announced that it has received a written notice (the "Notice") on November 14, 2024, from the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") stating that because the Company has not yet filed its Form 10-Q for the quarter ended September 30, 2024 (the "Q3 2024 Form 10-Q") and because the Company remains delinquent in filing its Form 10-Qs for the quarters ended March 31, 2024 (the "Q1 2024 Form 10-Q") and June 30, 2024 (the "Q2 2024 Form 10-Q") and its Form 10-K for the year ended December 31, 2023 (the "2023 Form 10-K", and collectively w
11/15/24 4:50:00 PM ET
$LUNA
Biotechnology: Commercial Physical & Biological Resarch
Health Care
Luna Innovations Announces CFO Transition: Names William Phelan as Chief Financial Officer and Chief Accounting Officer
Luna Innovations Incorporated (NASDAQ:LUNA), a global leader in advanced fiber optic-based technology, today announced the appointment of William L. Phelan as its new Chief Financial Officer and Chief Accounting Officer, effective immediately. Mr. Phelan succeeds John Roiko, who joined Luna out of retirement in May 2024 and played a key role in establishing a resilient foundation for Luna's future growth. Following the appointment of Mr. Phelan, Mr. Roiko will shift to a consulting role to support the ongoing restatement process. "We are delighted to welcome Bill to the Luna leadership team," said Kevin Ilcisin, President and CEO of Luna. "Bill's highly relevant experience will be instrume
10/16/24 4:30:00 PM ET
$LUNA
Biotechnology: Commercial Physical & Biological Resarch
Health Care
Luna Innovations Announces Receipt of Nasdaq Staff Determination Letter
Luna Innovations Incorporated (NASDAQ:LUNA) (the "Company"), a global leader in advanced fiber optic-based technology, today announced that on October 1, 2024, it received a staff determination letter (the "Letter") from the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") notifying the Company that, due to the Company's failure to regain compliance with Nasdaq Listing Rule 5250(c)(1) (the "Listing Rule"), which requires listed companies to timely file all required periodic financial reports with the Securities and Exchange Commission (the "SEC"), Nasdaq has determined (the "Determination") that the Company's securities will be scheduled for delisting from Nasdaq
10/7/24 4:30:00 PM ET
$LUNA
Biotechnology: Commercial Physical & Biological Resarch
Health Care

Luna Innovations Appoints Kevin Ilcisin As Its New President And CEO, Effective August 1, 2024

Chat with this insight

Recent Analyst Ratings for $LUNA

$LUNA Market Insights

Live Market Insights